Assessment of an RNA interference screen-derived mitotic and ceramide pathway metagene as a predictor of response to neoadjuvant paclitaxel for primary triple-negative breast cancer: a retrospective analysis of five clinical trials (Q39734181)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Assessment of an RNA interference screen-derived mitotic and ceramide pathway metagene as a predictor of response to neoadjuvant paclitaxel for primary triple-negative breast cancer: a retrospective analysis of five clinical trials |
scientific article |
Statements
1 reference
Assessment of an RNA interference screen-derived mitotic and ceramide pathway metagene as a predictor of response to neoadjuvant paclitaxel for primary triple-negative breast cancer: a retrospective analysis of five clinical trials (English)
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Christos Sotiriou
1 reference
W Fraser Symmans
1 reference
Lajos Pusztai
1 reference
Vicente Valero
1 reference
Rebecca A Burrell
1 reference
Qiyuan Li
1 reference
Eleni Andreopoulou
1 reference
26 February 2010
1 reference
1 reference
11
1 reference
4
1 reference
358-365
1 reference
Identifiers
1 reference
1 reference